PMID- 10226150 OWN - NLM STAT- MEDLINE DCOM- 19990712 LR - 20190513 IS - 0022-3751 (Print) IS - 1469-7793 (Electronic) IS - 0022-3751 (Linking) VI - 517 ( Pt 1) IP - Pt 1 DP - 1999 May 15 TI - Novel regulation of the A-type K+ current in murine proximal colon by calcium-calmodulin-dependent protein kinase II. PG - 75-84 AB - 1. The kinetics of inactivation of delayed rectifier K+ current in murine colonic myocytes differed in amphotericin-permeabilized patch and conventional patch clamp. The difference was accounted for by Ca2+ buffering. 2. Calcium-calmodulin-dependent protein kinase II (CaMKII) inhibitors increased the rate of inactivation and slowed recovery from inactivation of the outward current. This was seen in single steps and in the envelope of the current tails. The effect was largely on the TEA-insensitive component of current. 3. Dialysis of myocytes with autothiophosphorylated CaMKII slowed inactivation. This effect was reversed by addition of CaMKII inhibitor. 4. Antibodies revealed CaMKII-like immunoreactivity in murine colonic myocytes and other cells. Immunoblots identified a small protein with CaMKII-like immunoreactivity in homogenates of colonic muscle. 5. We conclude that CaMKII regulates delayed rectifier K+ currents in murine colonic myocytes. The changes in the delayed rectifier current may participate in the Ca2+-dependent regulation of gastrointestinal motility. FAU - Koh, S D AU - Koh SD AD - Department of Physiology and Cell Biology, University of Nevada School of Medicine, Reno, NV 89557, USA. skoh@physio.unr.edu FAU - Perrino, B A AU - Perrino BA FAU - Hatton, W J AU - Hatton WJ FAU - Kenyon, J L AU - Kenyon JL FAU - Sanders, K M AU - Sanders KM LA - eng GR - P01 DK041315/DK/NIDDK NIH HHS/United States GR - DK41315/DK/NIDDK NIH HHS/United States GR - NS36318/NS/NINDS NIH HHS/United States PT - Journal Article PT - Research Support, U.S. Gov't, P.H.S. PL - England TA - J Physiol JT - The Journal of physiology JID - 0266262 RN - 0 (Benzylamines) RN - 0 (Enzyme Inhibitors) RN - 0 (Sulfonamides) RN - 139298-40-1 (KN 93) RN - 63HM46XPOW (KN 62) RN - 84477-87-2 (1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine) RN - EC 2.7.11.17 (Calcium-Calmodulin-Dependent Protein Kinase Type 2) RN - EC 2.7.11.17 (Calcium-Calmodulin-Dependent Protein Kinases) RN - RWP5GA015D (Potassium) RN - SY7Q814VUP (Calcium) SB - IM MH - 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine/analogs & derivatives/pharmacology MH - Animals MH - Benzylamines/pharmacology MH - Calcium/metabolism MH - Calcium-Calmodulin-Dependent Protein Kinase Type 2 MH - Calcium-Calmodulin-Dependent Protein Kinases/antagonists & inhibitors/*metabolism MH - Colon/*metabolism MH - Enzyme Inhibitors/pharmacology MH - Gastrointestinal Motility/physiology MH - Immunohistochemistry MH - In Vitro Techniques MH - Kinetics MH - Mice MH - Mice, Inbred BALB C MH - Muscle, Smooth/metabolism MH - Patch-Clamp Techniques MH - Potassium/*metabolism MH - Sulfonamides/pharmacology PMC - PMC2269312 EDAT- 1999/05/05 00:00 MHDA- 1999/05/05 00:01 PMCR- 2000/05/15 CRDT- 1999/05/05 00:00 PHST- 1999/05/05 00:00 [pubmed] PHST- 1999/05/05 00:01 [medline] PHST- 1999/05/05 00:00 [entrez] PHST- 2000/05/15 00:00 [pmc-release] AID - 10.1111/j.1469-7793.1999.0075z.x [doi] PST - ppublish SO - J Physiol. 1999 May 15;517 ( Pt 1)(Pt 1):75-84. doi: 10.1111/j.1469-7793.1999.0075z.x.